En esta página
TRDA Entrada Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 5, 2026
$5,38
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$5,17mínimo 52 semanas
$16,45máximo 52 semanas
Capitalización Bursátil (MRQ)
$209M
P/E (TTM)
-1.4
BPA (TTM)
$-3.97
Ingresos (TTM)
$5M
tus insignias
Rango 52S
$5–$16
Calificación del Analista
BUY
Precio Objetivo
$19
P/E
-1.4
ROE
-54.1%
Margen de Beneficio Neto
-3537.7%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
TRDA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$5.38
Capitalización Bursátil (MRQ)
$209M
P/E (TTM)
-1.4
BPA (TTM)
$-3.97
Ingresos (TTM)
$5M
ROE (TTM)
-54.1%
Rango 52S
$5–$16
TRDA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$25M2023-12-31 → 2025-12-31
BPA$-3.472020-12-31 → 2025-12-31
Flujo de caja libre$-130M2021-12-31 → 2025-12-31
Margen neto-3537.7%2023-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | TRDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.4promedio 5A ≈-14.9 | ≈-14.9 | · | · | |
| P/S (TTM) | 44.7promedio 5A ≈7.5 | ≈7.5 | 16.1 | Sobrevalorado | |
| P/C (MRQ) | 0.9promedio 5A ≈1.7 | ≈1.7 | 1.3 | Valor razonable | |
| Precio / FCF (TTM) | -1.6promedio 5A ≈-5.9 | ≈-5.9 | · | · | |
| Precio / Flujo de Caja (TTM) | -1.6promedio 5A ≈-6.4 | ≈-6.4 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.7promedio 5A ≈1.7 | ≈1.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | TRDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -3767.1%promedio 5A ≈-200.4% | ≈-200.4% | -1601.1% | Débil | |
| EBITDA Margin (Margen EBITDA) | -621.1%promedio 5A ≈-200.4% | ≈-200.4% | -1600.0% | Débil | |
| Margen de Beneficio Neto (TTM) | -3537.7%promedio 5A ≈-179.8% | ≈-179.8% | -1943.2% | Débil | |
| ROA (TTM) | -44.3%promedio 5A ≈-12.4% | ≈-12.4% | -27.9% | Débil | |
| ROE (TTM) | -54.1%promedio 5A ≈-18.6% | ≈-18.6% | -27.2% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | TRDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 10.9promedio 5A ≈17.6 | ≈17.6 | 9.4 | En línea | |
| Quick Ratio (Ratio Rápido) | 3.7promedio 5A ≈12.5 | ≈12.5 | 7.4 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | TRDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -87.9% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | TRDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.1promedio 5A ≈0.3 | ≈0.3 | 0.1 | En línea | |
| Revenue / Employee (Ingresos / Empleado) | ≈$167.2K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
8.8%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 12, 2026 | $-1.01 | $-1.07 | 5.7% |
| 31 de marzo de 2026 | $-0.95 | $-1.06 | 10.2% | |
| 31 de diciembre de 2025 | $-0.94 | $-1.17 | 19.9% | |
| 30 de septiembre de 2025 | $-1.06 | $-0.96 | -10.6% | |
| 30 de junio de 2025 | $-1.04 | $-0.86 | -20.3% | |
| 31 de marzo de 2025 | $-0.42 | $-0.80 | 47.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $25M | $211M | $129M | |
| R&D Expense | $142M | $125M | $100M | |
| SG&A Expense | $41M | $38M | $32M | |
| Operating Expenses | $183M | $164M | $132M | |
| Operating Income | $-158M | $47M | $-3M | |
| Other Non-op | $15M | $19M | $15M | |
| Income Tax | $924.0K | $859.0K | $19M | |
| Net Income | $-144M | $66M | $-7M | |
| EPS (Basic) | $-3.47 | $1.76 | $-0.20 | |
| EPS (Diluted) | $-3.47 | $1.68 | $-0.20 | |
| Shares (Basic) | 41,371,486 | 37,306,363 | 33,050,319 | |
| Shares (Diluted) | 41,371,486 | 39,003,169 | 33,050,319 | |
| EBITDA | $-158M | $47M | $-3M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $90M | $101M | $68M | |
| Prepaid Expense | $9M | $16M | $12M | |
| Current Assets | $306M | $440M | $370M | |
| PP&E (Net) | $7M | $11M | $11M | |
| PP&E (Gross) | $17M | $20M | $17M | |
| Accum. Depreciation | $10M | $9M | $6M | |
| Other Non-current Assets | $70.0K | $284.0K | $3M | |
| Total Assets | $377M | $526M | $469M | |
| Accounts Payable | $2M | $4M | $3M | |
| Accrued Liabilities | $18M | $13M | $11M | |
| Current Liabilities | $24M | $39M | $159M | |
| Capital Leases | $47M | $52M | $60M | |
| Total Liabilities | $71M | $98M | $227M | |
| Common Stock | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | $579M | $558M | $437M | |
| Retained Earnings | $-273M | $-129M | $-195M | |
| AOCI | $652.0K | $-43.0K | $195.0K | |
| Stockholders' Equity | $306M | $429M | $242M | |
| Liabilities + Equity | $377M | $526M | $469M | |
| Shares Outstanding | 38,284,221 | 37,574,538 | 33,437,296 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $20M | $18M | $13M | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-129M | $-42M | $140M | |
| CapEx | $1M | $3M | $6M | |
| Investing Cash Flow | $117M | $-28M | $-138M | |
| Financing Cash Flow | $887.0K | $103M | $21M | |
| Net Change in Cash | $-11M | $34M | $22M | |
| Taxes Paid | $2M | $5M | $15M | |
| Free Cash Flow | $-130M | $-45M | $134M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -621.1% | 22.3% | -2.5% | |
| Net Margin | -565.5% | 31.1% | -5.2% | |
| EBITDA Margin | -621.1% | 22.3% | -2.5% | |
| ROA | -31.8% | 13.2% | -1.8% | |
| ROE | -41.9% | 15.4% | -2.7% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.5 | 11.1 | 2.3 | |
| Quick Ratio | 3.7 | 2.6 | 0.4 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.4 | 0.4 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $8.00 | $11.41 | $7.25 | |
| Revenue / Share | $0.61 | $5.40 | $3.90 | |
| Cash Flow / Share | $-3.11 | $-1.07 | $4.23 | |
| Cash / Share | $2.36 | $2.69 | $2.02 | |
| EPS (TTM) | $-3.47 | $1.68 | $-0.20 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -87.9% | 63.4% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $25M | $211M | $129M | |
| Net Income TTM | $-144M | $66M | $-7M | |
| Market Cap | $394M | $650M | $505M | |
| P/E | -3.0 | 10.3 | -75.5 | |
| P/S | 15.5 | 3.1 | 3.9 | |
| P/B | 1.3 | 1.5 | 2.1 | |
| P / Tangible Book | 1.3 | 1.5 | 2.1 | |
| P / Cash Flow | -3.1 | -15.6 | 3.6 | |
| P / FCF | -3.0 | -14.5 | 3.8 | |
| Earnings Yield | -33.8% | 9.7% | -1.3% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $898.0K | $875.0K | $1M | $2M | $2M | $21M | $37M | $20M | $95M | $59M | $42M | $44M | $18M | $25M | · | $0 | |
| R&D Expense | $35M | $33M | $34M | $38M | $38M | $32M | $33M | $31M | $32M | $29M | $28M | $22M | $26M | $23M | $16M | $19M | |
| SG&A Expense | $10M | $10M | $10M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $8M | $8M | $10M | $7M | |
| Operating Expenses | $46M | $43M | $44M | $49M | $49M | $42M | $43M | $41M | $41M | $38M | $37M | $30M | $34M | $31M | $26M | $26M | |
| Operating Income | $-45M | $-42M | $-42M | $-47M | $-47M | $-22M | $-6M | $-22M | $53M | $21M | $5M | $14M | $-16M | $-6M | $-26M | $-26M | |
| Other Non-op | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $3M | $950.0K | $799.0K | |
| Income Tax | $35.0K | $38.0K | $92.0K | $654.0K | $178.0K | $0 | $-2M | $-2M | $3M | $2M | $19M | $-17M | $14M | $4M | $0 | $0 | |
| Net Income | $-43M | $-40M | $-39M | $-44M | $-43M | $-17M | $1M | $-14M | $55M | $23M | $-10M | $35M | $-26M | $-7M | $-25M | $-25M | |
| EPS (Basic) | $-1.01 | $-0.95 | $-0.95 | $-1.06 | $-1.04 | $-0.42 | $-0.20 | $-0.35 | $1.61 | $0.70 | $-0.28 | $1.07 | $-0.78 | $-0.21 | $-0.79 | $-0.80 | |
| EPS (Diluted) | $-1.01 | $-0.95 | $-0.95 | $-1.06 | $-1.04 | $-0.42 | $-0.20 | $-0.35 | $1.55 | $0.68 | $-0.23 | $1.02 | $-0.78 | $-0.21 | $-0.79 | $-0.80 | |
| Shares (Basic) | 42,221,665 | 41,836,275 | · | 41,462,567 | 41,338,752 | 41,073,732 | · | 40,629,602 | 34,180,549 | 33,497,072 | · | 33,281,287 | 33,163,320 | 32,374,299 | · | 31,298,052 | |
| Shares (Diluted) | 42,221,665 | 41,836,275 | · | 41,462,567 | 41,338,752 | 41,073,732 | · | 40,629,602 | 35,507,029 | 34,790,925 | · | 34,775,451 | 33,163,320 | 32,374,299 | · | 31,298,052 | |
| EBITDA | $-45M | $-42M | · | $-47M | $-47M | $-22M | · | $-22M | $53M | $21M | · | $14M | $-16M | · | · | $-26M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $76M | $90M | $93M | $72M | $68M | $101M | $78M | $185M | $68M | $68M | $52M | $80M | $228M | $45M | $53M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $162M | |
| Prepaid Expense | $9M | $11M | $9M | $10M | $14M | $19M | $16M | $13M | $12M | $9M | $12M | $24M | $10M | $16M | $21M | $19M | |
| Current Assets | $233M | $267M | $306M | $338M | $369M | $403M | $440M | $465M | $490M | $414M | $370M | $383M | $390M | $434M | $210M | $235M | |
| PP&E (Net) | $6M | $7M | $7M | $8M | $10M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $9M | $8M | $7M | |
| PP&E (Gross) | $16M | $17M | $17M | $19M | $21M | $21M | $20M | $19M | $19M | $18M | $17M | $16M | $15M | $13M | $11M | $10M | |
| Accum. Depreciation | $11M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | $3M | |
| Other Non-current Assets | $118.0K | $90.0K | $70.0K | $163.0K | $199.0K | $239.0K | $284.0K | $746.0K | $747.0K | $3M | $3M | $3M | $538.0K | $14M | $5M | $954.0K | |
| Total Assets | $299M | $336M | $377M | $413M | $449M | $486M | $526M | $555M | $582M | $511M | $469M | $485M | $494M | $476M | $252M | $274M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $2M | $2M | $4M | $1M | $2M | $3M | $3M | $752.0K | $2M | $6M | $6M | $1M | |
| Accrued Liabilities | $13M | $12M | $18M | $16M | $12M | $8M | $13M | $13M | $11M | $9M | $11M | $10M | $7M | $12M | $8M | $12M | |
| Current Liabilities | $21M | $19M | $24M | $24M | $20M | $18M | $39M | $71M | $86M | $174M | $159M | $165M | $126M | $148M | $22M | $22M | |
| Capital Leases | $44M | $45M | $47M | $48M | $49M | $50M | $52M | $54M | $56M | $58M | $60M | $62M | $66M | $9M | $18M | $20M | |
| Total Liabilities | $65M | $65M | $71M | $72M | $69M | $69M | $98M | $132M | $152M | $241M | $227M | $238M | $287M | $246M | $40M | $41M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $589M | $583M | $579M | $574M | $569M | $564M | $558M | $552M | $547M | $441M | $437M | $433M | $429M | $425M | $403M | $400M | |
| Retained Earnings | $-356M | $-313M | $-273M | $-234M | $-190M | $-147M | $-129M | $-130M | $-116M | $-171M | $-195M | $-185M | $-221M | $-195M | $-188M | $-164M | |
| AOCI | $66.0K | $246.0K | $652.0K | $621.0K | $400.0K | $437.0K | $-43.0K | $972.0K | $-329.0K | $-246.0K | $195.0K | $-496.0K | $-1M | $-642.0K | $-2M | $-3M | |
| Stockholders' Equity | $233M | $271M | $306M | $341M | $380M | $417M | $429M | $422M | $430M | $269M | $242M | $247M | $207M | $230M | $213M | $233M | |
| Liabilities + Equity | $299M | $336M | $377M | $413M | $449M | $486M | $526M | $555M | $582M | $511M | $469M | $485M | $494M | $476M | $252M | $274M | |
| Shares Outstanding | 38,936,669 | 38,820,616 | 38,284,221 | 38,219,232 | 38,033,970 | 37,942,283 | 37,574,538 | 37,400,499 | 37,172,496 | 33,604,053 | 33,437,296 | 33,340,216 | 33,205,693 | 33,133,736 | 31,394,767 | 31,325,373 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-32M | $-42M | $-32M | $-28M | $-29M | $-39M | $-32M | $-24M | $40M | $-26M | $-4M | $-24M | $-35M | $203M | $-27M | $-27M | |
| CapEx | $11.0K | $44.0K | $-207.0K | $-171.0K | $275.0K | $1M | $635.0K | $639.0K | $1M | $838.0K | $976.0K | $1M | $2M | $2M | $708.0K | $810.0K | |
| Investing Cash Flow | $55M | $27M | $29M | $49M | $34M | $5M | $53M | $-83M | $-24M | $26M | $19M | $-4M | $-113M | $-40M | $19M | $-10M | |
| Stock Issued | · | · | · | $0 | · | · | · | $-392.0K | $100M | $0 | · | $0 | $0 | $19M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $350.0K | $100.0K | $192.0K | $8.0K | $337.0K | $350.0K | $1M | $-11.0K | $101M | $206.0K | $690.0K | $368.0K | $443.0K | $20M | $358.0K | $60.0K | |
| Net Change in Cash | $23M | $-15M | $-3M | $21M | $5M | $-33M | $23M | $-107M | $117M | $834.0K | $16M | $-28M | $-148M | $182M | $-8M | $-38M | |
| Free Cash Flow | · | $-42M | · | · | · | $-40M | · | · | · | $-26M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5007.0% | -4834.6% | · | -2915.2% | -2402.5% | -106.0% | · | -110.7% | 56.4% | 35.7% | · | 32.0% | -89.7% | · | · | · | |
| Net Margin | -4762.0% | -4539.1% | · | -2734.4% | -2210.4% | -84.4% | · | -71.7% | 58.1% | 39.7% | · | 81.1% | -142.7% | · | · | · | |
| EBITDA Margin | -5007.0% | -4834.6% | · | -2915.2% | -2402.5% | -106.0% | · | -110.7% | 56.4% | 35.7% | · | 32.0% | -89.7% | · | · | · | |
| ROA | -11.4% | -9.7% | · | -9.1% | -8.4% | -3.5% | · | -2.7% | 10.2% | 4.8% | · | 9.3% | -6.6% | · | · | -12.4% | |
| ROE | -14.0% | -11.5% | · | -11.6% | -10.7% | -5.1% | · | -4.2% | 17.3% | 9.4% | · | 14.8% | -11.2% | · | · | -31.3% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 13.9 | · | 14.1 | 18.6 | 21.9 | · | 6.6 | 5.7 | 2.4 | · | 2.3 | 3.1 | · | · | 10.9 | |
| Quick Ratio | 4.6 | 4.0 | · | 3.9 | 3.7 | 3.7 | · | 1.1 | 2.2 | 0.4 | · | 0.3 | 0.6 | · | · | 10.0 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.2 | 0.1 | · | 0.1 | 0.0 | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.99 | $6.98 | · | $8.91 | $9.98 | $11.00 | · | $11.30 | $11.57 | $8.02 | · | $7.40 | $6.23 | · | · | $7.45 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.04 | $0.05 | $0.50 | · | $0.48 | $2.67 | $1.70 | · | $1.26 | $0.55 | · | · | · | |
| Cash Flow / Share | · | $-1.00 | · | · | · | $-0.94 | · | · | · | $-0.73 | · | · | · | · | · | · | |
| Cash / Share | $2.55 | $1.97 | · | $2.44 | $1.91 | $1.79 | · | $2.09 | $4.98 | $2.04 | · | $1.56 | $2.40 | · | · | $1.70 | |
| EPS (TTM) | $-3.97 | $-4.00 | · | $-2.72 | $-2.01 | $0.58 | · | $1.65 | $3.02 | $0.69 | · | $-0.76 | $-2.58 | $-2.44 | · | $13.62 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $6M | · | $62M | $79M | $172M | · | $215M | $239M | $163M | · | · | · | $25M | · | · | |
| Net Income TTM | $-166M | $-166M | · | $-103M | $-73M | $25M | · | $55M | $104M | $23M | · | $-22M | $-82M | $-77M | · | $-88M | |
| Market Cap | $287M | $490M | · | $222M | $256M | $343M | · | $598M | $530M | $476M | · | $527M | $503M | · | · | $494M | |
| P/E | -1.9 | -3.2 | · | -2.1 | -3.3 | 15.6 | · | 9.7 | 4.7 | 20.5 | · | -20.8 | -5.9 | -5.9 | · | 1.2 | |
| P/S | 61.2 | 85.4 | · | 3.6 | 3.2 | 2.0 | · | 2.8 | 2.2 | 2.9 | · | · | · | · | · | · | |
| P/B | 1.2 | 1.8 | · | 0.7 | 0.7 | 0.8 | · | 1.4 | 1.2 | 1.8 | · | 2.1 | 2.4 | · | · | 2.1 | |
| P / Tangible Book | 1.2 | 1.8 | · | 0.7 | 0.7 | 0.8 | · | 1.4 | 1.2 | 1.8 | · | 2.1 | 2.4 | 2.1 | · | 2.1 | |
| P / Cash Flow | · | -11.8 | · | · | · | -8.9 | · | · | · | -18.7 | · | · | · | · | · | · | |
| Earnings Yield | -53.9% | -31.7% | · | -46.9% | -29.9% | 6.4% | · | 10.3% | 21.2% | 4.9% | · | -4.8% | -17.0% | -16.8% | · | 86.4% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $25M | $211M | $129M | · | · |
| Margen Operativo % | -621.1% | 22.3% | -2.5% | · | · |
| Beneficio neto | $-144M | $66M | $-7M | $-95M | $-51M |
| EPS Diluido | $-3.47 | $1.68 | $-0.20 | $-3.02 | $-8.16 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 12.5 | 11.1 | 2.3 | · | 44.5 |
| Ratio Rápido | 3.7 | 2.6 | 0.4 | · | 43.3 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-130M | $-45M | $134M | · | $-55M |
Propietarios institucionales (13F) 135 declarantes · $254.0M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
135
Valor en tenencia
$254.0M
Nuevas posiciones
28
Posiciones cerradas
16
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 28 (+6 vs trimestre anterior) | 16 (+4 vs trimestre anterior) | 53 (+6 vs trimestre anterior) | 31 (+1 vs trimestre anterior) | +2.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $37 335 293 | 5 072 730 | 14,70% | Acciones |
| 5AM Venture Management, LLC | $29 854 949 | 4 056 379 | 11,76% | Acciones |
| MPM ASSET MANAGEMENT LLC | $25 410 160 | 4 381 062 | 10,01% | Acciones |
| BlackRock, Inc. | $19 013 332 | 2 583 333 | 7,49% | Acciones |
| VANGUARD GROUP INC | $16 781 689 | 1 632 460 | 6,61% | Acciones |
| Merck & Co., Inc. | $12 804 692 | 1 739 768 | 5,04% | Acciones |
| StepStone Group LP | $9 607 316 | 761 277 | 3,78% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $9 344 506 | 1 269 634 | 3,68% | Acciones |
| MPM BIOIMPACT LLC | $9 222 470 | 1 253 053 | 3,63% | Acciones |
| TCG Crossover Management, LLC | $7 803 293 | 1 060 230 | 3,07% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $7 024 524 | 954 419 | 2,77% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $5 622 738 | 763 959 | 2,21% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $5 281 368 | 717 430 | 2,08% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $5 148 591 | 699 537 | 2,03% | Acciones |
| STATE STREET CORP | $4 391 543 | 596 677 | 1,73% | Acciones |
| JPMORGAN CHASE & CO | $3 827 683 | 496 457 | 1,51% | Acciones |
| CITADEL ADVISORS LLC | $2 902 217 | 394 323 | 1,14% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $2 769 577 | 376 136 | 1,09% | Acciones |
| NORTHERN TRUST CORP | $2 281 173 | 309 942 | 0,90% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2 233 458 | 303 459 | 0,88% | Acciones |
| Nantahala Capital Management, LLC | $2 212 232 | 300 575 | 0,87% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 870 397 | 254 130 | 0,74% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 450 921 | 197 136 | 0,57% | Acciones |
| Longaeva Partners L.P. | $1 436 944 | 195 237 | 0,57% | Acciones |
| MORGAN STANLEY | $1 410 544 | 191 650 | 0,56% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 405 760 | 191 000 | 0,55% | Acciones |
| Quantinno Capital Management LP | $1 389 855 | 188 839 | 0,55% | Acciones |
| Lynx1 Capital Management LP | $1 314 540 | 178 606 | 0,52% | Acciones |
| GOLDMAN SACHS GROUP INC | $1 305 247 | 177 343 | 0,51% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 233 875 | 167 646 | 0,49% | Acciones |
| Woodline Partners LP | $1 071 616 | 145 600 | 0,42% | Acciones |
| Trexquant Investment LP | $1 031 452 | 140 143 | 0,41% | Acciones |
| MOORE CAPITAL MANAGEMENT, LP | $772 800 | 105 000 | 0,30% | Acciones |
| Cubist Systematic Strategies, LLC | $711 521 | 122 676 | 0,28% | Acciones |
| XTX Topco Ltd | $701 680 | 95 337 | 0,28% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $699 524 | 95 044 | 0,28% | Acciones |
| Allspring Global Investments Holdings, LLC | $688 440 | 93 538 | 0,27% | Acciones |
| ROYCE & ASSOCIATES LP | $610 159 | 82 902 | 0,24% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $586 599 | 79 701 | 0,23% | Acciones |
| Bank of New York Mellon Corp | $581 955 | 79 070 | 0,23% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $533 747 | 72 520 | 0,21% | Acciones |
| AMERIPRISE FINANCIAL INC | $518 107 | 70 395 | 0,20% | Acciones |
| Qube Research & Technologies Ltd | $448 018 | 60 872 | 0,18% | Acciones |
| CANTOR FITZGERALD, L. P. | $441 600 | 60 000 | 0,17% | Acciones |
| BANK OF AMERICA CORP /DE/ | $426 343 | 57 927 | 0,17% | Acciones |
| Nuveen, LLC | $417 879 | 56 777 | 0,16% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $399 297 | 31 640 | 0,16% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $398 272 | 54 113 | 0,16% | Acciones |
| TD Asset Management Inc | $394 408 | 53 588 | 0,16% | Acciones |
| ExodusPoint Capital Management, LP | $388 365 | 52 767 | 0,15% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| ANSBERT GADICKE, LUKE EVNIN, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM Asset Management Investors BV2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM BIOVENTURES 2018, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, Todd Foley | 10 de septiembre de 2026 | 9,90% | Enmienda | · | SEC |
| 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar, Scott M. Rocklage | 18 de noviembre de 2025 | 10,80% | Enmienda | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker, Julian C. Baker ×2 presentaciones | 26 de junio de 2024 | · | Presentación inicial | Inversión pasiva | SEC |
| MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2018, L.P., MPM BioVentures 2018 (B), L.P., MPM Asset Management Investors BV2018 LLC, MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, Ansbert Gadicke, Luke Evnin, Todd Foley, Edward Hurwitz | 12 de noviembre de 2021 | · | Presentación inicial | Inversión pasiva | SEC |
| 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Dr. Kush Parmar, Dr. Scott M. Rocklage | 12 de noviembre de 2021 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 14 insiders · 5 directivos · 10 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Dipal Doshi | CEO | 2 de septiembre de 2026 F | 517 290 | 0 | 0 | $0 |
| Kory James Wentworth | Chief Financial Officer | 2 de septiembre de 2026 F | 117 277 | 0 | 5 | $-433 579 |
| Natarajan Sethuraman | President, Research & Develop. | 2 de septiembre de 2026 F | 214 238 | 0 | 1 | $-398 709 |
| Nathan J Dowden | President & COO | 2 de septiembre de 2026 F | 196 060 | 0 | 3 | $-425 737 |
| Nerissa Kreher | Chief Medical Officer | 1 de septiembre de 2023 A | 40 037 | 0 | 0 | $0 |
| Kush Parmar | Consejero | 10 de agosto de 2026 S | 2 691 337 | 0 | 6 | $-3 645 964 |
| Maha Radhakrishnan | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Gina Chapman | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Bernhardt G Zeiher | Consejero | 10 de junio de 2026 A | 5 000 | 1 | 0 | $29 300 |
| Mary Thistle | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Peter S Kim | Consejero | 10 de junio de 2026 A | 117 412 | 0 | 0 | $0 |
| John F Crowley | Consejero | 8 de junio de 2023 A | 5 000 | 0 | 0 | $0 |
| Carole Nuechterlein | Consejero | 2 de junio de 2022 A | · | 0 | 0 | $0 |
| Todd Foley | Consejero | 2 de junio de 2022 A | 4 425 784 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 23 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,15% | 1 770 SH | 11 de septiembre de 2026 | Diario |
| HAPS · Harbor ETF Trust | 0,13% | 33 369 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,04% | 100 286 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 2 754 SH | 1 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,01% | 203 253 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 169 170 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 25 636 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 27 123 SH | 1 de octubre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 14 068 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 753 989 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 108 498 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2 856 NS | 31 de julio de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 12 272 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3 020 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4 231 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4 896 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 7 674 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 283 038 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 953 727 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 999 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 2 069 NS | 31 de julio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,00% | 57 325 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 269 374 SH | 11 de septiembre de 2026 | Diario |
TRDA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$20.00
+271,7%
5 35,7%
Compra fuerte
7 50,0%
Compra
2 14,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-10-03Objetivo medio $19.00 +253,2%
← Por Debajo de Todos los Objetivos
Precio Actual $5.38
Mín$11.00
Media$19.00
Máx$25.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 5, 2026